MSB 2.10% $1.17 mesoblast limited

Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-348

  1. 3,314 Posts.
    lightbulb Created with Sketch. 2850
    We won awards like that 10 years ago - "Biotech of the Year" back in the Cephalon days mate - do you know about that? Maybe before your time.
    They are meaningless, except for obscure groups of insiders who don't need to be told.

    Market research lists have been reprinted here many times showing global organizations working in our area.
    Last one I recall listed about 60 companies. Not one mention of MSB.
    We are virtually unknown.

    I follow the US media 24/7. (Australian media not so much) A few weeks ago they were falling over themselves to report on Gilead - the vendors of the totally discredited junk drug remdesivir. That was long before Trump got the virus. They were INVITED into the White House to talk to Trump about providing remdesivir to the American people for emergency use. All this time, with the "know all" Fauci on hand to provide comment to Congress - never a single word about Mesoblast!! They don't know about it - or don't WANT to know about it!
    We are virtually unknown.

    The "2020 Fierce Innovation" will be fish and chip paper in quick time.


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.17
Change
-0.025(2.10%)
Mkt cap ! $1.330B
Open High Low Value Volume
$1.18 $1.22 $1.15 $6.344M 5.404M

Buyers (Bids)

No. Vol. Price($)
1 8683 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.17 32999 1
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.